M B Faletto

1.6k total citations
18 papers, 1.4k citations indexed

About

M B Faletto is a scholar working on Molecular Biology, Cancer Research and Plant Science. According to data from OpenAlex, M B Faletto has authored 18 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Plant Science. Recurrent topics in M B Faletto's work include Carcinogens and Genotoxicity Assessment (8 papers), Mycotoxins in Agriculture and Food (7 papers) and Pharmacogenetics and Drug Metabolism (6 papers). M B Faletto is often cited by papers focused on Carcinogens and Genotoxicity Assessment (8 papers), Mycotoxins in Agriculture and Food (7 papers) and Pharmacogenetics and Drug Metabolism (6 papers). M B Faletto collaborates with scholars based in United States and Canada. M B Faletto's co-authors include Jorge Goldstein, Judy L. Raucy, Susan M. Daluge, M H St Clair, Steven S. Good, Wayne H. Miller, Jerome M. Lasker, Terry Sullivan, Burhan I. Ghanayem and Sutisak Kitareewan and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

M B Faletto

18 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M B Faletto United States 11 621 444 407 324 247 18 1.4k
Bryan A. Ward United States 7 677 1.1× 233 0.5× 450 1.1× 392 1.2× 252 1.0× 8 1.4k
Kristina Campanale United States 10 300 0.5× 368 0.8× 250 0.6× 175 0.5× 131 0.5× 17 1.1k
Gloria Y. Kwei United States 14 348 0.6× 339 0.8× 139 0.3× 324 1.0× 83 0.3× 28 1.2k
J H Lin United States 11 439 0.7× 299 0.7× 122 0.3× 344 1.1× 65 0.3× 13 1.1k
Shangara S. Dehal United States 19 584 0.9× 418 0.9× 123 0.3× 275 0.8× 51 0.2× 27 1.5k
Praveen Balimane United States 21 334 0.5× 559 1.3× 260 0.6× 952 2.9× 56 0.2× 34 2.1k
Huy Riêm Ha Switzerland 16 504 0.8× 246 0.6× 258 0.6× 482 1.5× 55 0.2× 21 1.3k
John Tjia United Kingdom 17 332 0.5× 162 0.4× 725 1.8× 203 0.6× 452 1.8× 23 1.3k
Caroline A. Lee United States 19 691 1.1× 277 0.6× 166 0.4× 590 1.8× 30 0.1× 27 1.4k
Joy A. Nishime United States 11 316 0.5× 116 0.3× 229 0.6× 283 0.9× 140 0.6× 14 690

Countries citing papers authored by M B Faletto

Since Specialization
Citations

This map shows the geographic impact of M B Faletto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M B Faletto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M B Faletto more than expected).

Fields of papers citing papers by M B Faletto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M B Faletto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M B Faletto. The network helps show where M B Faletto may publish in the future.

Co-authorship network of co-authors of M B Faletto

This figure shows the co-authorship network connecting the top 25 collaborators of M B Faletto. A scholar is included among the top collaborators of M B Faletto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M B Faletto. M B Faletto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Faletto, M B, Wayne H. Miller, Edward P. Garvey, et al.. (1997). Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89. Antimicrobial Agents and Chemotherapy. 41(5). 1099–1107. 186 indexed citations
2.
Nadadur, Srikanth S., et al.. (1997). Altered biochemical profile and gene expression in aflatoxin B-1-transformed C3H10T1/2 cells. International Journal of Oncology. 10(6). 1265–75. 4 indexed citations
3.
Daluge, Susan M., Steven S. Good, M B Faletto, et al.. (1997). 1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity. Antimicrobial Agents and Chemotherapy. 41(5). 1082–1093. 323 indexed citations
4.
Faletto, M B, Wayne H. Miller, Edward P. Garvey, et al.. (1995). Unique purine crossover activation pathway for the potent anti-HIV agent 1592U89. Antiviral Research. 26(3). A262–A262. 3 indexed citations
5.
Goldstein, Jorge, M B Faletto, Terry Sullivan, et al.. (1994). Evidence That CYP2C19 is the Major (S)-Mephenytoin 4'-Hydroxylase in Humans. Biochemistry. 33(7). 1743–1752. 316 indexed citations
6.
Habib, Samy L., Frank A. Scappaticci, M B Faletto, et al.. (1994). Altered Expression of Cytochrome P450 mRNA during Chemical-Induced Hepatocarcinogenesis and Following Partial Hepatectomy. Toxicology and Applied Pharmacology. 124(1). 139–148. 13 indexed citations
7.
Goldstein, Jorge & M B Faletto. (1993). Advances in mechanisms of activation and deactivation of environmental chemicals.. Environmental Health Perspectives. 100. 169–176. 62 indexed citations
8.
Kaminsky, Laurence S., et al.. (1993). Correlation of human cytochrome P4502C substrate specificities with primary structure: warfarin as a probe.. Molecular Pharmacology. 43(2). 234–239. 126 indexed citations
9.
Goldstein, Joyce A. & M B Faletto. (1993). Advances in Mechanisms of Activation and Deactivation of Environmental Chemicals. Environmental Health Perspectives. 100. 169–169. 5 indexed citations
10.
Faletto, M B, Patricia Linko, & Jorge Goldstein. (1992). A single amino acid mutation (Ser180----Cys) determines the polymorphism in cytochrome P450g (P4502C13) by altering protein stability.. Journal of Biological Chemistry. 267(3). 2032–2037. 26 indexed citations
11.
Faletto, M B, et al.. (1992). Aflatoxin-transformed C3H/10T1/2 cells overexpress protein kinase C and have an altered response to phorbol ester treatments.. PubMed. 52(4). 990–6. 9 indexed citations
12.
Romkes, Marjorie, M B Faletto, Joyce Blaisdell, Judy L. Raucy, & Jorge Goldstein. (1991). Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily. Biochemistry. 30(13). 3247–3255. 178 indexed citations
13.
Faletto, M B, et al.. (1990). Altered benzo[a]pyrene metabolism in C3H/10T12 cells transformed by aflatoxin B1 or 3-methylcholanthrene. Toxicology and Applied Pharmacology. 104(2). 351–366. 4 indexed citations
14.
Faletto, M B & Hira L. Gurtoo. (1989). The effect of inducers of mixed-function oxidases on hepatic microsome-mediated aflatoxin B1 transformation in C3H10T12 cells. Toxicology and Applied Pharmacology. 98(2). 252–262. 6 indexed citations
15.
Faletto, M B, Paul L. Koser, Narayana Battula, et al.. (1988). Cytochrome P3-450 cDNA encodes aflatoxin B1-4-hydroxylase.. Journal of Biological Chemistry. 263(25). 12187–12189. 46 indexed citations
16.
Koser, Paul L., M B Faletto, A. E. Maccubbin, & Hira L. Gurtoo. (1988). The genetics of aflatoxin B1 metabolism. Association of the induction of aflatoxin B1-4-hydroxylase with the transcriptional activation of cytochrome P3-450 gene.. Journal of Biological Chemistry. 263(25). 12584–12595. 36 indexed citations
17.
Koser, Paul L., M B Faletto, S. K. Bansal, et al.. (1987). Aflatoxin B1-4-hydroxylase is associated with cytochrome P3-450 in C57BL6 mouse liver. Biochemical and Biophysical Research Communications. 142(3). 872–878. 5 indexed citations
18.
Bertram, John S. & M B Faletto. (1985). Requirements for and kinetics of growth arrest of neoplastic cells by confluent 10T1/2 fibroblasts induced by a specific inhibitor of cyclic adenosine 3':5'-phosphodiesterase.. PubMed. 45(5). 1946–52. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026